Fiscal year ending 2024. Filed on March 3, 2025.
29 Broadway 4th Floor
Mall
New York, New York 10006
Cancer Research Institute Inc. (EIN: 13-1837442) has filed an IRS Form 990 since fiscal year 2017. In its fiscal year 2024 IRS Form 990 filing, Cancer Research Institute Inc., a 501(c)(3) charitable organization, reported compensation for 14 out of 32 total employees. Among the employees shown here, the average compensation is $294,175. The highest compensated employee at Cancer Research Institute Inc. is Jill O'Donnell Tormey To 824 with fiscal year 2024 compensation of $612,021.
Revenue
Expenses
Employee compensation
SEE SCHEDULE OTHE CANCER RESEARCH INSTITUTE'S MISSION IS TO SAVE MORE LIVES BY FUELING THE DISCOVERY AND DEVELOPMENT OF POWERFUL IMMUNOTHERAPIES FOR ALL TYPES OF CANCER. TO ACCOMPLISH THIS, CRI FUNDS LABORATORY, TRANSLATIONAL, AND CLINICAL RESEARCH. EFFORTS AIMED AT LEARNING HOW TO HARNESS THE POWER OF THE IMMUNE SYSTEM TO DIAGNOSE, TREAT, AND CURE CANCER. CRI ALSO COORDINATES SCIENTIFIC, MEDICAL, AND PATIENT EDUCATION CONFERENCES ON THE SUBJECTS OF IMMUNOLOGY AND IMMUNOTHERAPY, AND DISSEMINATES INFORMATION IN ENGLISH AND SPANISH ABOUT ADVANCES IN TUMOR IMMUNOLOGY TO THE MEDIA, PUBLIC, AND MEDICAL AND SCIENTIFIC COMMUNITIES.
Be the first to know when new IRS Form 990 data is published for this organization.